Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Buys Abbott's Ophthalmics Business For $4bn-Plus

Executive Summary

The move to sell Abbott Medical Optics unit comes in the midst of a significant portfolio overhaul by Abbott. The deal will put J&J in the ophthalmic surgery business.

You may also be interested in...



Medtech Veteran Robert Ford Will Take Over As Abbott CEO From Miles White

Abbott’s current COO Robert Ford will become the company’s new CEO on 31 March, 2020. Miles White is stepping down after 21 years leading the diversified health-care products company.

Earnings Winners & Losers: The Large Diversified Firms, ABT, BAX, CAH, JNJ

Most of the large, diversified medtech companies have now reported their sales and earnings for the second quarter and first half of 2017. All of the companies in this category reported revenue growth and promised investment in new technologies across all their businesses, but a Baxter and Cardinal Health stand out as having especially successful quarters. Abbott is still trying to overcome major challenges, and J&J is turning around its medical device businesses under new leadership.

International Headwinds Counter J&J's Beauty Business Buoyancy

"Some much weaker markets and some macroeconomic conditions, particularly in China and India" prompt J&J to adjust its overall and consumer business expectations, CFO Dominic Caruso says. The firm's consumer product revenues climbed 1.7% to $3.5bn in is latest quarter.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT103841

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel